Financial Daily from THE HINDU group of publications
Wednesday, Sep 29, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - New Projects


Shantha Biotech vaccine plant inaugurated

Our Bureau


A view of the new plant belonging to Shantha Biotechnics Pvt Ltd near Hyderabad on Tuesday. The 80,000-sq ft facility was constructed at a cost of Rs 40 crore. - A. Roy Chowdhury

Hyderabad , Sept. 28

THE new vaccine manufacturing facility of Shantha Biotechnics Pvt Ltd was inaugurated on Tuesday by the Chief Minister, Dr Y.S. Rajasekhara Reddy.

Built at a cost of Rs 40 crore, the 80,000 square foot, the Good Manufacturing Practises (GMP) compliant facility, has three production suites that would enable the company produce several types of vaccines, the Managing Director, Mr Varaprasad Reddy, said.

According to him, the new facility would initially produce DPT (Diphtheria, Pertussis and Tetanus) vaccine and these antigens would be conjugated with the Hepatitis-B vaccine to make the combination DPT-HepB vaccine. The company's R&D has successfully completed the formulation of the combination vaccine that would soon be rolled out from the new facility.

Stating that the company also plans to have a comprehensive vaccines portfolio to service the markets in the developing countries, Mr Reddy said the introduction of the first indigenously produced combination DPT-Hepatitis B vaccine would further the company's efforts in this direction.

According to him, combination vaccines were considered important as they reduce the number of injections an infant receives, thereby achieving more compliance in the immunisation of the new born. Though many countries now endorse preference to introduce combination vaccines, the combo vaccines currently being produced by a handful of multinational pharmaceutical companies were expensively priced thus making it difficult for these countries to provide such vaccines to its people at affordable prices, he said.

Stating that the company's affordable pricing strategy would lessen the burden on immunisation programmes of various governments of the underdeveloped countries in Asia, Africa and Latin America, Mr Reddy presented one-lakh paediatric dosages of Hepatitis-B vaccine to the AP Chief Minister to be distributed in the latter's `Rajeev Palle Bata' programme.

More Stories on : New Projects | Bio-tech & Genetics | Andhra Pradesh

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Zee Tele gets nod to launch sports channel


Biocon begins phase-II trials of cancer drug
D-Link AGM okays dividend
Pilani Investments' AGM not to be an all-Birla affair
Zee has not met eligibility criteria: ESPN-Star
`BPL dispute will be resolved amicably'
Halcyon takeover: Kerala HC declines stay
BHEL net profit rises 48 pc to Rs 658 cr — To pay 60 per cent
Global brewers keen on UB stake: Mallya
Elder Pharma gets nod to sell stake to Italian co
Axles India to put up Rs 16-cr plant for Dana Corp supplies
Shantha Biotech vaccine plant inaugurated
McPhar, Alcock join hands for oil, mineral surveys
SAIL, Kudremukh in pact
Welcome bags 5 more hotels
Deepak Fertilizers plans specialty mall in Pune
Hyundai upbeat on response to Getz
Ruchi Soya sees 15% topline growth
Tata Chemicals in talks with IOC for LNG supply
Martial Rolland to take over reins of Nestle India
JB Chem gets new R&D V-P



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line